Investment Banking

Europe set for biggest M&A payday as Takeda greenlit for $62bn Shire buy

Acquisition of UK-listed company will be largest-ever foreign takeover by a Japanese company

The global HQ of Takeda Pharmaceutical in Tokyo, Japan
The global HQ of Takeda Pharmaceutical in Tokyo, Japan Photo: Getty Images

Six investment banks are set to share a fee pool of more than $260m after shareholders approved pharmaceutical giant Takeda’s $62bn acquisition of UK-listed Shire, in what will be the biggest payday for European M&A this year.

Evercore, JPMorgan and Nomura advised Takeda on the deal, which is the largest-ever overseas acquisition by a Japanese company. US investment banks Citigroup, Goldman Sachs and Morgan Stanley advised Shire.

WSJ Logo
Europe Draws Up Retaliatory Tariffs for U.S. Goods in Case No Trade Deal Is ReachedExternal link

Europe Draws Up Retaliatory Tariffs for U.S. Goods in Case No Trade Deal Is Reached